Nature - T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa
Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South AfricaNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South AfricaSA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South...
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Lire la suite »
Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Lire la suite »
Can cannabis protect people from COVID? Buzzy studies can't say.A new study cannot say whether CBD or other cannabis products are helpful against the virus, while researchers call for clinical trials.
Lire la suite »